AUTHOR INDEX
 |
|
| Browse by letter: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
|
|
|
|
|
|
|
|
|
Search results for: "S"
Results 321 - 330 of 992 shown below |
|
|
|
|
|
|
|
| Sebret, Angélique |
|
| Valérie Daugé, Angélique Sebret, Françoise Beslot, Toshimitsu Matsui and Bernard P Roques Behavioral Profile of CCK2 Receptor-deficient Mice doi:10.1016/S0893-133X(01)00291-3 Neuropsychopharmacology 25, 690-698 | Abstract | Full text | PDF | |
|
|
|
| Sechter, D |
|
| D Sechter, J Peuskens, O Fleurot, W Rein and Y Lecrubier Amisulpride vs Risperidone in Chronic Schizophrenia: Results of a 6-Month, Double-Blind Study doi:10.1038/sj.npp.1300174 Neuropsychopharmacology 28, 611-611 | Abstract | Full text | PDF | |
|
|
|
| Sechter, Daniel |
|
| Daniel Sechter, Joseph Peuskens, Odile Fleurot, Werner Rein and Yves Lecrubier Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study doi:10.1016/S0893-133X(02)00375-5 Neuropsychopharmacology 27, 1071-1081 | Abstract | Full text | PDF | |
|
|
|
| Seckin, Esen |
|
| Una D McCann, Zsolt Szabo, Esen Seckin, Peter Rosenblatt, William B Mathews, Hayden T Ravert, Robert F Dannals and George A Ricaurte Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB doi:10.1038/sj.npp.1300736 Neuropsychopharmacology 30, 1741-1750 | Abstract | Full text | PDF | |
|
|
|
| Seckl, Jonathan R |
|
| Joyce L W Yau, June Noble, Sarah Thomas, Robert Kerwin, Phillip E Morgan, Stafford Lightman, Jonathan R Seckl and Carmine M Pariante The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice doi:10.1038/sj.npp.1301389 Neuropsychopharmacology 32, 2520-2529 | Abstract | Full text | PDF | |
|
|
|
| Secunda, Steven |
|
| Martin M Katz, Charles Bowden, Peter Stokes, Regina Casper, Alan Frazer, Stephen H Koslow, James Kocsis, Steven Secunda, Alan Swann and Nancy Berman Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment? doi:10.1016/S0893-133X(97)00038-9 Neuropsychopharmacology 17, 110-112 | Abstract | PDF | |
|
|
|
| Sedvall, Göran C |
|
| Göran C Sedvall and Per Karlsson Pharmacological Manipulation of D1-Dopamine Receptor Function in Schizophrenia doi:10.1038/sj.npp.1395428 Neuropsychopharmacology 21, S181-S188 | Abstract | PDF | |
|
|
|
| See, Ronald E |
|
| Christopher C Ledford, Rita A Fuchs and Ronald E See Potentiated Reinstatement of Cocaine-Seeking Behavior Following D-amphetamine Infusion into the Basolateral Amygdala doi:10.1038/sj.npp.1300249 Neuropsychopharmacology 28, 1721-1729 | Abstract | Full text | PDF | |
|
|
|
| Rita A Fuchs, K Allison Evans, Christopher C Ledford, Macon P Parker, Jordan M Case, Ritu H Mehta and Ronald E See The Role of the Dorsomedial Prefrontal Cortex, Basolateral Amygdala, and Dorsal Hippocampus in Contextual Reinstatement of Cocaine Seeking in Rats doi:10.1038/sj.npp.1300579 Neuropsychopharmacology 30, 296-309 | Abstract | Full text | PDF | |
|
|
|
| Tod E Kippin, Karen K Szumlinski, Zuzana Kapasova, Betsy Rezner and Ronald E See Prenatal Stress Enhances Responsiveness to Cocaine doi:10.1038/sj.npp.1301447 Neuropsychopharmacology 33, 769-782 | Abstract | Full text | PDF | |
|
|
|
| Jeffrey W Grimm and Ronald E See Dissociation of Primary and Secondary Reward-Relevant Limbic Nuclei in an Animal Model of Relapse doi:10.1016/S0893-133X(99)00157-8 Neuropsychopharmacology 22, 473-479 | Abstract | Full text | PDF | |
|
|
|
| Seeman, P |
|
| P Seeman, R Corbett and H H M Van Tol doi:10.1016/S0893-133X(96)00193-5 Neuropsychopharmacology 16, 127-135 | Abstract | PDF | |
|
|
|
| Seeman, Philip |
|
| Jesse R Schank, Rossella Ventura, Stefano Puglisi-Allegra, Antonio Alcaro, Charlene D Cole, L Cameron Liles, Philip Seeman and David Weinshenker Dopamine  -Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocainedoi:10.1038/sj.npp.1301000 Neuropsychopharmacology aop, - | |
|
|
|
| Matthäus Willeit, Nathalie Ginovart, Ariel Graff, Pablo Rusjan, Irina Vitcu, Sylvain Houle, Philip Seeman, Alan A Wilson and Shitij Kapur First Human Evidence of d-Amphetamine Induced Displacement of a D2/3 Agonist Radioligand: A [11C]-(+)-PHNO Positron Emission Tomography Study doi:10.1038/sj.npp.1301400 Neuropsychopharmacology 33, 279-289 | Abstract | Full text | PDF | |
|
|
|
| Frank P Bymaster, David O Calligaro, Julie F Falcone, Richard D Marsh, Nicholas A Moore, Nicholas C Tye, Philip Seeman and David T Wong Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine doi:10.1016/0893-133X(94)00129-N Neuropsychopharmacology 14, 87-96 | Abstract | PDF | |
|
|
|
| Philip Seeman, Roy Corbett and Hubert H M Van Tol Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors doi:10.1016/S0893-133X(96)00187-X Neuropsychopharmacology 16, 93-110 | Abstract | PDF | |
|
|
|
| Shitij Kapur, Susan C Barsoum and Philip Seeman Dopamine D2 Receptor Blockade by Haloperidol: 3H-Raclopride Reveals Much Higher Occupancy than EEDQ doi:10.1016/S0893-133X(00)00139-1 Neuropsychopharmacology 23, 595-598 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | |
 Previous
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
